Structure of the active pharmaceutical ingredient bismuth subsalicylate

被引:0
|
作者
Erik Svensson Grape
Victoria Rooth
Mathias Nero
Tom Willhammar
A. Ken Inge
机构
[1] Stockholm University,Department of Materials and Environmental Chemistry
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Structure determination of pharmaceutical compounds is invaluable for drug development but remains challenging for those that form as small crystals with defects. Bismuth subsalicylate, among the most commercially significant bismuth compounds, is an active ingredient in over-the-counter medications such as Pepto-Bismol, used to treat dyspepsia and H. pylori infections. Despite its century-long history, the structure of bismuth subsalicylate is still under debate. Here we show that advanced electron microscopy techniques, namely three-dimensional electron diffraction and scanning transmission electron microscopy, can give insight into the structure of active pharmaceutical ingredients that are difficult to characterize using conventional methods due to their small size or intricate structural features. Hierarchical clustering analysis of three-dimensional electron diffraction data from ordered crystals of bismuth subsalicylate revealed a layered structure. A detailed investigation using high-resolution scanning transmission electron microscopy showed variations in the stacking of layers, the presence of which has likely hindered structure solution by other means. Together, these modern electron crystallography techniques provide a toolbox for structure determination of active pharmaceutical ingredients and drug discovery, demonstrated by this study of bismuth subsalicylate.
引用
收藏
相关论文
共 50 条
  • [1] Structure of the active pharmaceutical ingredient bismuth subsalicylate
    Grape, Erik Svensson
    Rooth, Victoria
    Nero, Mathias
    Willhammar, Tom
    Inge, A. Ken
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [2] Bismuth gallate coordination networks inspired by an active pharmaceutical ingredient
    Grape, Erik Svensson
    Rooth, Victoria
    Smolders, Simon
    Thiriez, Ambre
    Takki, Sofia
    De Vos, Dirk
    Willhammar, Tom
    Inge, A. Ken
    DALTON TRANSACTIONS, 2022, 51 (37) : 14221 - 14227
  • [3] Elucidation of the elusive structure and formula of the active pharmaceutical ingredient bismuth subgallate by continuous rotation electron diffraction
    Wang, Yunchen
    Takki, Sofia
    Cheung, Ocean
    Xu, Hongyi
    Wan, Wei
    Ohrstrom, Lars
    Inge, A. Ken
    CHEMICAL COMMUNICATIONS, 2017, 53 (52) : 7018 - 7021
  • [4] Bismuth subsalicylate in the cecum
    Hellmig, S
    Stüber, E
    Katsoulis, S
    Fölsch, UR
    GASTROINTESTINAL ENDOSCOPY, 2002, 56 (04) : 565 - 565
  • [5] In the pink with bismuth subsalicylate
    Inge, A. Ken
    NATURE CHEMISTRY, 2024, 16 (07) : 1210 - 1210
  • [6] ASPIRIN AND BISMUTH SUBSALICYLATE
    LEVY, G
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (12): : 1281 - 1281
  • [7] Bismuth Subsalicylate Poisoning
    Meaden, Christopher W.
    Calello, Diane P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (22): : 2074 - 2074
  • [8] Investigation of active pharmaceutical ingredient loss in pharmaceutical compounding of capsules
    D'Hondt, Matthias
    Wynendaele, Evelien
    Vandercruyssen, Kirsten
    Bauters, Tiene
    Vandenbroucke, Johan
    Mullens, Steven
    Vervaet, Chris
    Remon, Jean Paul
    De Spiegeleer, Bart
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 96 : 68 - 76
  • [9] Site of Bismuth Absorption from Bismuth Subsalicylate
    Fabrizis L. Suarez
    Julie Furne
    Janet Stiehm
    Cindy Garten
    Michael D. Levitt
    Digestive Diseases and Sciences, 2000, 45 : 1444 - 1446
  • [10] Preparation of Bismuth Subsalicylate from Bismuth Subnitrate
    Koledova, E. S.
    Yukhin, Yu. M.
    THEORETICAL FOUNDATIONS OF CHEMICAL ENGINEERING, 2024, 58 (01) : 71 - 75